Purpose Although the prevalence of community-acquired respiratory bacterial coinfection
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …

ABSTRACT Background: Procalcitonin (PCT) and C-Reactive Protein (CRP) are useful
biomarkers to differentiate bacterial from viral or fungal infections, although the association …

Abstract Purpose Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
coronavirus 2 (SARS-CoV-2) has spread around the world. Differentiation between pure …

Background A low procalcitonin (PCT) concentration facilitates exclusion of bacterial co-
infections in COVID-19, but high costs associated with PCT measurements preclude …

Objectives We described the current incidence and risk factors of bacterial co-infection in
hospitalized patients with COVID-19. Methods Observational cohort study was performed at …

Background To characterise the longitudinal dynamics of C-reactive protein (CRP) and
Procalcitonin (PCT) in a cohort of hospitalised patients with COVID-19 and support …

Objectives Procalcitonin (PCT) is an acute-phase reactant with concentrations≥ 0.5 μg/L
indicative of possible bacterial infection in patients with SARS-CoV-2 infection (COVID-19) …

Purpose Coronavirus disease-2019 (COVID-19) is associated with a wide spectrum of
clinical symptoms including acute respiratory failure. Biomarkers that can predict outcomes …

Background This study aimed to assess and compare procalcitonin (PCT) and C-reactive
protein (CRP) levels between COVID-19 and non-COVID-19 sepsis patients. Additionally …

Purpose To investigate antimicrobial use and primary and nosocomial infections in
hospitalized COVID-19 patients to provide data for guidance of antimicrobial therapy …